A recent study published in the Pain Physicians Journal reports that the orthobiologic therapy bone marrow aspirate concentrate (BMAC), shows significant promise as a non-surgical alternative treatment options for patients diagnosed with chronic lumbar spinal degeneration. Orthobiologic therapies such as bone marrow aspirate concentrate utilize a concentrated dose of autologous cells (cells extracted from ones own body) to enhance the body’s natural ability to repair or in some instances replace damaged tissue.
regenerative medicine

The study compared patients diagnosed with severe chronic low back pain due to spinal degeneration being treated with BMAC against patients treated with traditional pain management therapies. The treatment group received a one-time bone marrow aspirate concentrate injection into the affected area of the lumbar spine combined with traditional pain management therapies. The control group received only traditional pain management offerings (i.e. injections, anti-inflammatory drugs, prescribed medications, over-the-counter medications, physical therapy, ect.) Patients we studied over a period of twelve months, with outcomes being recorded at 1, 3, 6 and 12 months.

Patients in the treatment group showed significant improvement in function and pain reduction when compared to the control group at the twelve month assessment. For the full results of the study, follow the provided link below.